Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Chugai Pharmaceutical Co Ltd (CHGCF)
OTHER OTC:CHGCF
RESEARCH TOOLSreports
Holding CHGCF?
Track your performance easily
CHGCF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$28.60 - $53.52
Previous Close$38.46
Volume7.18K
Average Volume (3M)17.90K
Market Cap
$67.04B
Enterprise Value$63.51B
Total Cash (Recent Filing)¥545.29B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)24.6
Beta0.64
Next Earnings
Jan 30, 2025EPS Estimate
$0.37Last Dividend Ex-Date
Jun 27, 2024Dividend Yield1.39%
Share Statistics
EPS (TTM)1.56
Shares OutstandingN/A
10 Day Avg. Volume2,516
30 Day Avg. Volume17,901
Standard Deviation0.14
R-Squared0.00147
Alpha0.00950
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)4.81
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$49.61Price Target Upside22.65% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
Chugai Pharmaceutical Co News
PremiumCompany Announcements
Chugai Pharmaceuticals Revises Financial Forecasts
PremiumCompany Announcements
Chugai Pharmaceutical Boosts 2024 Revenue Forecast
PremiumCompany Announcements
Chugai Pharmaceutical Reports Strong Financial Growth in 2024
PremiumCompany Announcements
Chugai Pharmaceutical Corrects Financial Statements
PremiumCompany Announcements
Chugai Pharmaceutical’s H1 Profits and Dividends Up
PremiumCompany Announcements
Chugai Pharmaceutical Included in Roche’s 2024 Results
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
4.95% Mutual Funds
0.08% Other Institutional Investors
91.23% Public Companies and
Individual Investors
CHGCF FAQ
What was Chugai Pharmaceutical Co Ltd’s price range in the past 12 months?
Chugai Pharmaceutical Co Ltd lowest stock price was $28.60 and its highest was $53.52 in the past 12 months.
What is Chugai Pharmaceutical Co Ltd’s market cap?
Currently, no data Available
When is Chugai Pharmaceutical Co Ltd’s upcoming earnings report date?
Chugai Pharmaceutical Co Ltd’s upcoming earnings report date is Jan 30, 2025 which is in 65 days.
How were Chugai Pharmaceutical Co Ltd’s earnings last quarter?
Chugai Pharmaceutical Co Ltd released its earnings results on Oct 25, 2024. The company reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.39 by $0.04.
Is Chugai Pharmaceutical Co Ltd overvalued?
According to Wall Street analysts Chugai Pharmaceutical Co Ltd’s price is currently Undervalued.
Does Chugai Pharmaceutical Co Ltd pay dividends?
Chugai Pharmaceutical Co Ltd pays a Annually dividend of $0.26 which represents an annual dividend yield of 1.39%. See more information on Chugai Pharmaceutical Co Ltd dividends here
What is Chugai Pharmaceutical Co Ltd’s EPS estimate?
Chugai Pharmaceutical Co Ltd’s EPS estimate is $0.37.
How many shares outstanding does Chugai Pharmaceutical Co Ltd have?
Chugai Pharmaceutical Co Ltd has 1,679,057,600 shares outstanding.
What happened to Chugai Pharmaceutical Co Ltd’s price movement after its last earnings report?
Chugai Pharmaceutical Co Ltd reported an EPS of $0.43 in its last earnings report, beating expectations of $0.39. Following the earnings report the stock price went down -0.438%.
Which hedge fund is a major shareholder of Chugai Pharmaceutical Co Ltd?
Currently, no hedge funds are holding shares in CHGCF
---
Chugai Pharmaceutical Co Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
16.35%
12-Months-Change
Fundamentals
Return on Equity
22.46%
Trailing 12-Months
Asset Growth
18.79%
Trailing 12-Months
Company Description
Chugai Pharmaceutical Co Ltd
Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of the pharmaceuticals. Its operations are carried out through the following business divisions: Research, Development, Production, Marketing, Medical Affairs and Drug Safety. The Research division focuses its efforts on creating innovative drugs by using its competitive strengths that include proprietary antibody technologies and cutting-edge research resources. The Development division provides cross-functional lifecycle management system to deliver innovative medicines to patients as quickly as possible. The Production division provides a world-class safety and quality management systems. The Marketing division conducts patient-oriented marketing activities to help solve issues related to healthcare. The Medical Affairs division works to properly deliver the value of medicines based on global compliance standards. The Drug Safety provides safety management system includes expert safety evaluation as well as timely gathering and reporting of safety information. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.
---
CHGCF Company Deck
---
CHGCF Earnings Call
Q2 2024
0:00 / 0:00
---
CHGCF Stock 12 Month Forecast
Average Price Target
$49.61
▲(22.65% Upside)
Technical Analysis
Best Analysts Covering CHGCF
1 Year
---